Scancell Holdings (SCLP)

 

SCLP Share PerformanceMore

52 week high16.950 24/08/17
52 week low9.675 11/05/17
52 week change -2.250 (-15.25%)
4 week volume3,913,207 17/11/17

Media for (SCLP)

Presenter: Dr Richard Goodfellow
30/07/2015
Presenter: Dr Richard Goodfellow
01/06/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Trends and Targets for 8/12/2017

FTSE FOR FRIDAY (FTSE:UKX) Sometimes, the utter boredom inflicted by the market leads one down a strange path. Th...

Result of AGM

RNS Number: 3096T Scancell Holdings Plc 11 October 2017 11 October 2017 Scancell Holdings Plc ("Scancell" or the "Company") Results of AGM Scancell Holdings Plc, (AIM:SCLP), the developer of novel immunotherapies for the treatment of cancer, announces that all resolutions proposed at the Annual General Meeting were duly passed. For Further Information: Dr ...

Directorate Change

RNS Number: 1039T Scancell Holdings Plc 10 October 2017 10 October 2017 Scancell Holdings Plc ("Scancell" or the "Company") Scancell appoints Dr Cliff Holloway as Chief Executive Officer Experienced life sciences executive with in-depth oncology expertise Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatmen...

Notice of AGM

RNS Number: 6869Q Scancell Holdings Plc 14 September 2017 14 September 2017 Scancell Holdings Plc ("Scancell" or the "Company") Notice of AGM Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, will host its Annual General Meeting on Tuesday 10 October 2017. The AGM details are as follows: ...

Weak mining and consumer stocks hit FTSE

Mining stocks were the main casualties this morning as BHP Billiton (BLT), Fresnillo (FRES) and Anglo American (AAL) ...

Scancell reports good progress in development of Modi-1

Scancell reported continued good progress in development of Modi-1, the lead product from the Moditope platform in the y...

Final Results

RNS Number: 5643Q Scancell Holdings Plc 13 September 2017 13 September 2017 Scancell Holdings Plc ("Scancell" or the "Company") Final Results for the year ended 30 April 2017 Landmark five year survival achieved in resected SCIB1 patients Emerging pipeline of three products across five cancer indications Scancell Holdings plc, ('Group' or the 'Company') the dev...

Presents Moditope Data at Immunotherapy Conference

RNS Number: 2969Q Scancell Holdings Plc 11 September 2017 11 September 2017 Scancell Holdings Plc ("Scancell" or the "Company") Scancell Presents Moditope Data at the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of c...

Fundamental DataMore

EPS-1.36
Dividend yield0 %

Latest discussion posts More

  • NEW ARTICLE: Trends and Targets for 8/12/2017

    " FTSE FOR FRIDAY (FTSE:UKX) Sometimes, the utter boredom inflicted by the market leads one down a strange path. Thursday was a case in point, the morning session used ...
    7-Dec-2017
    II Editor
  • Some good publicity

    Scancell was in last weekend's FT alongside two other AIM companies: https://www.ft.com/content/5e49e822-828c-11e7-a4ce-15b2513cb3ff That could explain the recent rise ...
    23-Aug-2017
    Michaelhighbar
  • Re: Acceleratred book buid placing RNS

    Just looked at LSE site posts on there within two mins of RNS... 12.09 / 12.11 .. with links Must check over there in future.
    13-May-2017
    Ripley94

Users' HoldingsMore

Users who hold Scancell Holdings also hold..

Codes & Symbols

ISINGB00B63D3314
SymbolsSCLP, LSE:SCLP, SCLP.L, SCLP:LN, LON:SCLP, XLON:SCLP

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account